LEADER 00972nam0-22003251i-450-
001 990003058650403321
035   $a000305865
035   $aFED01000305865
035   $a(Aleph)000305865FED01
035   $a000305865
100   $a20000920d1968----km-y0itay50------ba
101 0 $aita
102   $aIT
200 1 $aEconomic Development and Planning in Egypt$fMagdi M. El-Kammash$gForeword by Joseph J. Spengler.
210   $aNew York$cFrederick A. Praeger$d1968.
215   $aXXVI, 408 p.$d24 cm
225 1 $aPraeger special studies in international economics and development
610 0 $aEgitto$aSviluppo economico
676   $aF/1.111
676   $aF/3.2
676   $aN/1.5
702  1$aEl-Kammash,$bMagdi M.
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990003058650403321
952   $aF/1.111 ELK$b2379/I$fSES
959   $aSES
996   $aEconomic Development and Planning in Egypt$9465362
997   $aUNINA
DB    $aING01

LEADER 01308nam--2200409---450-
001 990000425030203316
005 20090713134831.0
010   $a88-324-9697-6
035   $a0042503
035   $aUSA010042503
035   $a(ALEPH)000042503USA01
035   $a0042503
100   $a20010504d1995----km-y0itay0103----ba
101   $ait
102   $aITA
105   $a||||||||001yy
200 1 $a<<L'>> assicurazione sulla vita$ediritto,fisco, tecnica assicurativa$eaggiornato con il D. lgs. 174/95 di attuazione della direttva 92/96 CEE$fClaudio Bazzano$gpresentazione di Alfonso Desiata
205   $a2. ed.
210   $aMilano$cPirola$d1995
215   $aXXVI, 300 p.$d24 cm
300   $aIn cop.: Pirola Legale
410   $12001
606 0 $aAssicurazioni vita
676   $a346.4508632
700  1$aBAZZANO,$bClaudio$0117492
702  1$aDESIATA,$bAlfonso
801  0$aIT$bsalbc$gISBD
912   $a990000425030203316
951   $aXXV.1.H 195 (IG I 1163 A)$b20561 G$cXXV.1.H 195 (IG I 1163 A)$d00236786
959   $aBK
969   $aGIU
979   $aPATTY$b90$c20010504$lUSA01$h1034
979   $c20020403$lUSA01$h1650
979   $aPATRY$b90$c20040406$lUSA01$h1629
979   $aRSIAV1$b90$c20090713$lUSA01$h1348
996   $aAssicurazione sulla vita$9466782
997   $aUNISA

LEADER 02087nam  2200493 a 450 
001 9910790211203321
005 20200520144314.0
010   $a1-61470-069-9
035   $a(CKB)2670000000149454
035   $a(EBL)3019757
035   $a(SSID)ssj0000690231
035   $a(PQKBManifestationID)12331028
035   $a(PQKBTitleCode)TC0000690231
035   $a(PQKBWorkID)10620628
035   $a(PQKB)11099867
035   $a(MiAaPQ)EBC3019757
035   $a(Au-PeEL)EBL3019757
035   $a(CaPaEBR)ebr10671322
035   $a(OCoLC)846943406
035   $a(EXLCZ)992670000000149454
100   $a20081119d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aImmunologic adjuvant research$b[electronic resource] /$fAntonio H. Benvenuto, editor
210   $aHauppauge, N.Y. $cNova Science$dc2009
215   $a1 online resource (140 p.)
300   $aDescription based upon print version of record.
311   $a1-60692-399-4 
320   $aIncludes bibliographical references and index.
327   $aAdjuvants in cancer vaccinations / Ralf Kircheis, Andreas Nechansky -- TLR agonists as immune adjuvants / Yanal Murad, Bara Sarraj -- Modulating immune response with CpG-oligodeoxynucleotide through the skin / Joe Inoue, Yukihiko Aramaki -- Immunopotentiating reconstituted influenza virosomes as safe and potent antigen-delivery system for synthetic peptides in vaccines development / Claudia A. Daubenberger ... [et al.] -- Vaccine adjuvants : priorities and challenges / Ali M. Harandi, Ole F. Olesen -- The involvement of interleukin-6 in the augmentation of immune response by immunologic adjuvants / Masahiko Mihara, Hiroto Yoshida.
606   $aImmunological adjuvants
615  0$aImmunological adjuvants.
676   $a571.9/645
701   $aBenvenuto$b Antonio$f1945-$01573498
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910790211203321
996   $aImmunologic adjuvant research$93849245
997   $aUNINA